Gatiray P Eye Drop is a combination ophthalmic solution containing Gatifloxacin (0.3% w/v), a broad-spectrum fluoroquinolone antibiotic, and Prednisolone (1% w/v), a corticosteroid with potent anti-inflammatory properties. This formulation is indicated for the treatment of bacterial infections of the eye accompanied by inflammation, such as conjunctivitis, keratitis, and other ocular surface infections. Gatifloxacin acts by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial replication and effectively eradicating susceptible pathogens. Prednisolone reduces inflammation by suppressing the migration of polymorphonuclear leukocytes and reversing capillary permeability, which helps alleviate symptoms such as redness, swelling, and discomfort. Gatiray P Eye Drop should be used under strict medical supervision, as inappropriate use of corticosteroids may lead to increased intraocular pressure, delayed wound healing, or secondary infections. The dosage and duration of therapy must be tailored to the severity of the infection and response to treatment. Patients are advised to avoid contamination of the dropper tip and to discontinue use if adverse reactions such as increased eye pain, vision changes, or hypersensitivity occur. This combination provides an effective therapeutic approach for managing bacterial ocular infections with associated inflammation.